,Group,Gilenya_pat,Gilenya_relapse,Gilenya_relapse_rate,Tecfidera_pat,Tecfidera_relapse,Tecfidera_relapse_rate,actual_treatment,expect_Gilenya_relapse_rate,expect_Tecfidera_relapse_rate,expect_treatment
training,lowest 35%,531,46,0.0866290018832392,490,88,0.179591836734694,-0.0929628348514547,0.0865733913470341,0.181871617686608,-0.0952982263395735
training,middle 30%,361,33,0.0914127423822715,319,41,0.128526645768025,-0.0371139033857536,0.109317380007284,0.141342450098191,-0.032025070090907
training,highest 35%,446,75,0.168161434977578,531,59,0.111111111111111,0.0570503238664674,0.157027615433712,0.10134169225639,0.0556859231773227
test,lowest 50%,180,19,0.105555555555556,168,21,0.125,-0.0194444444444444,0.0929937643591664,0.171895551872782,-0.0789017875136161
test,highest 50%,156,24,0.153846153846154,166,22,0.132530120481928,0.0213160333642261,0.14889640577636,0.107961989326949,0.040934416449411
